查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949078

全球周邊神經損傷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Peripheral Nerve Injuries Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2025 年，周邊神經損傷市場規模將達到 20.9 億美元，到 2034 年將達到 41.6 億美元，2026 年至 2034 年的複合年成長率為 7.93%。

由於神經損傷及相關疾病的發生率不斷上升，周邊神經損傷市場正經歷顯著成長。周邊神經損傷可由創傷、手術或疾病引起，導致疼痛、肌肉無力和功能喪失。糖尿病等疾病的日益流行和人口老化推動了對有效治療方法的需求，包括手術干預、神經修復裝置和復健療法。隨著醫療機構致力於改善患者預後和恢復功能，周邊神經損傷治療市場預計將持續擴張。

技術創新在塑造周邊神經損傷市場的未來中發揮關鍵作用。微創手術和神經移植等外科技術的進步正在改善治療效果，而先進生物材料和神經導管的研發則促進了受損神經的再生和修復。隨著製造商持續加大研發投入，預計創新解決方案將在各種醫療機構中得到更廣泛的應用。

此外，以病人為中心的照護和復原理念日益受到重視，這也推動了周邊神經損傷市場的成長。隨著患者尋求滿足其復健需求的綜合解決方案，將手術介入與復健療法結合的綜合治療方案的需求也日益成長。這一趨勢促使醫療服務提供者、復健專業人員和科技公司之間加強合作，共同開發促進康復和提高生活品質的整體方法。隨著市場的不斷發展，技術應用、患者參與和全面多學科護理將成為成功的關鍵促進因素。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球周邊神經損傷市場（按類型分類）

  • 市場分析、洞察與預測
  • 神經麻痺
  • 軸突損傷
  • 神經斷裂

5. 全球周邊神經損傷市場（依治療方法）

  • 市場分析、洞察與預測
  • 外科
  • 非手術

6. 全球周邊神經損傷市場（依最終用戶分類）

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他

7. 全球周邊神經損傷市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic Plc
    • Stryker Corporation
    • Baxter International Inc
    • Axogen Inc
    • Integra LifeSciences Holdings Corporation
    • Boston Scientific Corporation
    • Abbott Laboratories
    • NeuroPace Inc
    • NeuroMetrix Inc
    • Polyganics BV
    • Toyobo Co. Ltd
    • Synovis Micro Companies Alliance Inc
    • Collagen Matrix Inc
    • Nuvectra Corporation
    • Nevro Corp
簡介目錄
Product Code: VMR11219104

The Peripheral Nerve Injuries Market size is expected to reach USD 4.16 Billion in 2034 from USD 2.09 Billion (2025) growing at a CAGR of 7.93% during 2026-2034.

The Peripheral Nerve Injuries Market is experiencing significant growth as the incidence of nerve injuries and related disorders increases. Peripheral nerve injuries can result from trauma, surgery, or medical conditions, leading to pain, weakness, and loss of function. The rising prevalence of conditions such as diabetes and the growing aging population are driving the demand for effective treatment options, including surgical interventions, nerve repair devices, and rehabilitation therapies. As healthcare providers seek to improve patient outcomes and restore function, the market for peripheral nerve injury treatments is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the peripheral nerve injuries market. Innovations in surgical techniques, such as minimally invasive procedures and nerve grafting, are enhancing the effectiveness of treatments. Additionally, the development of advanced biomaterials and nerve conduits is improving the regeneration and repair of damaged nerves. As manufacturers continue to invest in research and development, the peripheral nerve injuries market is likely to see increased adoption of innovative solutions across various healthcare settings.

Moreover, the growing emphasis on patient-centered care and rehabilitation is influencing the peripheral nerve injuries market's growth trajectory. As patients seek comprehensive solutions that address their recovery needs, there is a rising demand for integrated treatment plans that combine surgical interventions with rehabilitation therapies. This trend is driving collaboration between healthcare providers, rehabilitation specialists, and technology firms to develop holistic approaches that enhance recovery and improve quality of life. As the market continues to evolve, the integration of technology, patient engagement, and multidisciplinary care will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Neuropraxia
  • Axonotmesis
  • Neurotmesis

By Treatment

  • Surgical
  • Non-Surgical

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

COMPANIES PROFILED

  • Medtronic plc, Stryker Corporation, Baxter International Inc, Axogen Inc, Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, Abbott Laboratories, NeuroPace Inc, NeuroMetrix Inc, Polyganics BV, Toyobo Co Ltd, Synovis Micro Companies Alliance Inc, Collagen Matrix Inc, Nuvectra Corporation, Nevro Corp

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERIPHERAL NERVE INJURIES MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Neuropraxia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Axonotmesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Neurotmesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERIPHERAL NERVE INJURIES MARKET: BY TREATMENT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Treatment
  • 5.2. Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Non-Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERIPHERAL NERVE INJURIES MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERIPHERAL NERVE INJURIES MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Treatment
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Treatment
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Treatment
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Treatment
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Treatment
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PERIPHERAL NERVE INJURIES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Medtronic Plc
    • 9.2.2 Stryker Corporation
    • 9.2.3 Baxter International Inc
    • 9.2.4 Axogen Inc
    • 9.2.5 Integra LifeSciences Holdings Corporation
    • 9.2.6 Boston Scientific Corporation
    • 9.2.7 Abbott Laboratories
    • 9.2.8 NeuroPace Inc
    • 9.2.9 NeuroMetrix Inc
    • 9.2.10 Polyganics B.V
    • 9.2.11 Toyobo Co. Ltd
    • 9.2.12 Synovis Micro Companies Alliance Inc
    • 9.2.13 Collagen Matrix Inc
    • 9.2.14 Nuvectra Corporation
    • 9.2.15 Nevro Corp